Trade Tonix Pharmaceuticals Holding Corp. - TNXP CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.54 |
| Open | 0.53 |
| 1-Year Change | -69.01% |
| Day's Range | 0.52 - 0.54 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 0.55 | 0.01 | 1.85% | 0.54 | 0.57 | 0.44 |
| Jul 24, 2024 | 0.50 | -0.08 | -13.79% | 0.58 | 0.58 | 0.50 |
| Jul 23, 2024 | 0.54 | 0.00 | 0.00% | 0.54 | 0.54 | 0.52 |
| Jul 22, 2024 | 0.53 | -0.04 | -7.02% | 0.57 | 0.57 | 0.52 |
| Jul 19, 2024 | 0.54 | -0.01 | -1.82% | 0.55 | 0.55 | 0.54 |
| Jul 18, 2024 | 0.55 | -0.03 | -5.17% | 0.58 | 0.58 | 0.54 |
| Jul 17, 2024 | 0.57 | -0.01 | -1.72% | 0.58 | 0.58 | 0.57 |
| Jul 16, 2024 | 0.59 | 0.01 | 1.72% | 0.58 | 0.59 | 0.57 |
| Jul 15, 2024 | 0.57 | -0.02 | -3.39% | 0.59 | 0.59 | 0.56 |
| Jul 12, 2024 | 0.58 | -0.01 | -1.69% | 0.59 | 0.61 | 0.58 |
| Jul 11, 2024 | 0.59 | -0.01 | -1.67% | 0.60 | 0.62 | 0.58 |
| Jul 10, 2024 | 0.59 | 0.01 | 1.72% | 0.58 | 0.60 | 0.57 |
| Jul 9, 2024 | 0.58 | 0.02 | 3.57% | 0.56 | 0.60 | 0.56 |
| Jul 8, 2024 | 0.68 | -0.13 | -16.05% | 0.81 | 0.81 | 0.67 |
| Jul 5, 2024 | 0.77 | -0.10 | -11.49% | 0.87 | 0.92 | 0.77 |
| Jul 3, 2024 | 0.84 | 0.15 | 21.74% | 0.69 | 0.87 | 0.69 |
| Jul 2, 2024 | 0.71 | 0.01 | 1.43% | 0.70 | 0.72 | 0.66 |
| Jul 1, 2024 | 0.69 | 0.01 | 1.47% | 0.68 | 0.72 | 0.65 |
| Jun 28, 2024 | 0.67 | -0.02 | -2.90% | 0.69 | 0.69 | 0.65 |
| Jun 27, 2024 | 0.66 | 0.06 | 10.00% | 0.60 | 0.69 | 0.57 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Tonix Pharmaceuticals Holding Corp. Company profile
Tonix Pharmaceuticals Holding Corp. (TNXP) is a clinical-stage biopharmaceutical company that focuses on understanding diseases and developing innovative therapies with the potential to address unmet needs.
Headquartered in Chatham, New Jersey, Tonix Pharma was founded in 2007 with the idea of developing a diverse yet curated portfolio of small molecule drugs across various therapeutic areas, like the central nervous system (CNS), immunology, infectious disease and rare diseases. With a significant investment in in-house research and development and manufacturing, Tonix Pharma accelerates the drug development and reachability timeline and can respond immediately in case of an infectious disease breakout.
The company’s CNS portfolio comprises TNX-102 SL (Confirmatory Phase 3) for Fibromyalgia. Drugs in phase 2 development are TNX-102 SL for Posttraumatic Stress Disorder (PTSD), TNX-102 SL for long Covid, TNX-1300 for cocaine overdose and TNX-1900 for chronic migraine. It also has two drugs in the preclinical phase: TNX-1500 for organ transplant rejection/autoimmune disorders and TNX-1700 for gastric and colorectal cancers.
Pathogenic infections like smallpox and monkeypox have been a core area of focus for Tonix for a long time, however, the Covid-19 outbreak pushed the company to focus on rapid preparedness to combat infectious diseases. The company has the TNX-1840/1850 Covid-19 vaccine, TNX-3500 Covid-19 antiviral, TNX-3600 Covid-19 therapeutic and TNX-801 smallpox and monkeypox vaccine under development and in preclinical stages.
Tonix’s rare disease portfolio includes TNX-2900 for Prader-Willi syndrome, which is in the preclinical stage.
Tonix shares began trading under the ticker symbol ‘TNXP’ on the Nasdaq Capital Market in August 2013.
| Industry: | Bio Therapeutic Drugs |
26 Main Street, Suite 101
CHATHAM
NEW JERSEY 07928
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com